“It's just encouraging them to think about it in a different way. And in a way, I think that the pandemic has accelerated this, because we have people all over the world working together. And if you do have that structure sorted out, it makes your life a lot easier.”

Leader in biomedical and epi-informatic data science, Paul Agapow turns big data into tremendous medical value to help mankind. We had the opportunity to chat with him and discover the impact that AI is having on pharmaceuticals.